Daniel L. Reuvers net worth and biography

Daniel Reuvers Biography and Net Worth

Mr. Reuvers joined Tactile in June 2020 from Integra LifeSciences Corporation, where he served as the Executive Vice President and President, Codman Specialty Surgical, since December 2016. His responsibilities there included global sales, marketing, product development, quality and regulatory, and service and repair. He joined Integra in 2008 as Vice President of Marketing & Product Development for the company’s surgical instrument business, and held a series of roles with progressively increased responsibility. Among his accomplishments there, he led the $1B acquisition and integration of the Codman business from Johnson & Johnson. Previously, he served as President of Advanced Respiratory and Omni-Tract Surgical, both resulting in acquisitions by Hill-Rom and Integra, respectively.Mr. Reuvers served on the board of Respirtech, Inc. for 10 years, until their acquisition by Philips.We believe Mr. Reuvers is qualified to serve on our Board of Directors because of his extensive commercial and general management experience in the medtech industry.

What is Daniel L. Reuvers' net worth?: The estimated net worth of Daniel L. Reuvers is at least $3.24 million as of February 24th, 2025. Mr. Reuvers owns 242,942 shares of Tactile Systems Technology stock worth more than $3,238,417 as of April 8th. This net worth evaluation does not reflect any other investments that Mr. Reuvers may own. Additionally, Mr. Reuvers receives a salary of $1,220,000.00 as CEO at Tactile Systems Technology. Learn More about Daniel L. Reuvers' net worth.
How old is Daniel L. Reuvers?: Mr. Reuvers is currently 61 years old. There are 1 older executives and no younger executives at Tactile Systems Technology. Learn More on Daniel L. Reuvers' age.
What is Daniel L. Reuvers' salary?: As the CEO of Tactile Systems Technology, Inc., Mr. Reuvers earns $1,220,000.00 per year. Learn More on Daniel L. Reuvers' salary.
How do I contact Daniel L. Reuvers?: The corporate mailing address for Mr. Reuvers and other Tactile Systems Technology executives is 3701 Wayzata Blvd Suite 300, MINNEAPOLIS MN, 55413. Tactile Systems Technology can also be reached via phone at (612) 355-5100 and via email at investorrelations@tactilemedical.com. Learn More on Daniel L. Reuvers' contact information.
Has Daniel L. Reuvers been buying or selling shares of Tactile Systems Technology?: Daniel L. Reuvers has not been actively trading shares of Tactile Systems Technology within the last three months. Most recently, Daniel L. Reuvers sold 10,938 shares of the business's stock in a transaction on Monday, February 24th. The shares were sold at an average price of $14.55, for a transaction totalling $159,147.90. Following the completion of the sale, the director now directly owns 242,942 shares of the company's stock, valued at $3,534,806.10. Learn More on Daniel L. Reuvers' trading history.
Who are Tactile Systems Technology's active insiders?: Tactile Systems Technology's insider roster includes William Burke (Director), and Daniel Reuvers (CEO). Learn More on Tactile Systems Technology's active insiders.
Are insiders buying or selling shares of Tactile Systems Technology?: In the last year, insiders at the sold shares 6 times. They sold a total of 25,902 shares worth more than $373,906.43. The most recent insider tranaction occured on February, 24th when Director Daniel L Reuvers sold 10,938 shares worth more than $159,147.90. Insiders at Tactile Systems Technology own 1.0% of the company. Learn More about insider trades at Tactile Systems Technology.
Information on this page was last updated on 2/24/2025.

Daniel L. Reuvers Insider Trading History at Tactile Systems Technology

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/24/2025	Sell	10,938	$14.55	$159,147.90	242,942
2/29/2024	Sell	1,396	$15.25	$21,289.00	238,027
2/26/2024	Sell	6,239	$15.81	$98,638.59	244,112
2/23/2024	Sell	5,378	$14.85	$79,863.30	192,321
8/7/2023	Sell	1,062	$20.53	$21,802.86	125,653
2/27/2023	Sell	6,387	$15.27	$97,529.49	127,415
8/8/2022	Sell	1,020	$9.18	$9,363.60	74,707
2/28/2022	Sell	877	$19.78	$17,347.06
8/6/2021	Sell	1,063	$43.11	$45,825.93	22,667

Daniel L. Reuvers Buying and Selling Activity at Tactile Systems Technology

Tactile Systems Technology Company Overview

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Today's Range

Now: $13.33

$12.30

$13.96

50 Day Range

MA: $15.00

$13.00

$17.99

2 Week Range

Now: $13.33

$11.12

$21.10

Volume

308,812 shs

Average Volume

248,258 shs

Market Capitalization

$315.47 million

P/E Ratio

19.04

Dividend Yield

N/A

Beta

1.21

Daniel Reuvers Biography and Net Worth

What is Daniel L. Reuvers' net worth?

How old is Daniel L. Reuvers?

What is Daniel L. Reuvers' salary?

How do I contact Daniel L. Reuvers?

Has Daniel L. Reuvers been buying or selling shares of Tactile Systems Technology?

Who are Tactile Systems Technology's active insiders?

Are insiders buying or selling shares of Tactile Systems Technology?